Wuxi, China-based biologics
technology platform company WuXi Biologics
Kirti Ganorkar, global head, portfolio management and business development, Sun Pharma, said, "Samsung BioLogics
is a globally renowned CMO.
, a company involved in clinical and commercial manufacturing of monoclonal antibodies, coagulation factors and other therapeutic proteins, has signed a definitive agreement with AGC Asahi Glass, a manufacturer of glass, chemicals and high-tech materials.
Market by Product Type (Bone Graft, Bine Graft Substitute, Platelet Rich Plasma, BMAC), Surgery Type (Anterior Cervical Discectomy and Fusion, Posterior Lumbar Interbody Fusion), End User, and Geography - Global Forecast to 2020
The workshop will focus on how state regulations and so-called naming conventions may impact the development of, and competition for, follow-on biologics
In situations in which there is active infection or significant contamination, biologic
grafts may not be appropriate as they deteriorate as a result of the bacterial collagenases.
Of the 3,189 RA patients who had received at least one course of rituximab in the clinical trial, 283 were subsequently treated with an alternative biologic
agent during safety follow-up, according to Dr.
6) In other words, the very population of patients meant to be served by novel, biologic
treatments is deprived of their promise primarily because of cost; with added, undesirable societal burden fraught with economic consequences.
1548), which provides 12 years of data exclusivity to brand-name biologic
The facility will support increased production capacity for ORENCIA[R] (abatacept), the company's first internally discovered and developed biologic
medicine, and also manufacture commercial quantities of compounds currently in development should those compounds receive regulatory approval.
In a sense, the chromosome contains two intertwined types of information: the linear sequence of nucleotide bases in DNA codes for biologic
macromolecules, and the regulatory information embedded in the nucleoprotein architecture of chromatin specifies which regions of the genome are active in any given cell.
These data are generally obtained from a combination of sentinel surveillance methods and biologic
testing as part of community population surveys.